Hutchin Hill Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hutchin Hill Capital's BMY Position: Q1 2017 in Review
Hutchin Hill Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 28,522 shares — an estimated $1.56M sold.
Hutchin Hill Capital first reported a position in BMY in Q2 2013 and held it in 9 quarters. The position peaked at $2.48M in Q2 2013. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Hutchin Hill Capital reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
- Hutchin Hill Capital sold 28,522 Bristol-Myers Squibb shares in Q1 2017, an estimated $1.56M.
- Hutchin Hill Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 9 quarters.
- Hutchin Hill Capital's Bristol-Myers Squibb position peaked at $2.48M in Q2 2013.
- 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.